The levels of circulating caspase-4 were significantly higher in the plasma of lung cancer patients (LC; n = 125) than healthy non-smoker, non-pathological subjects (H; n = 79) (Figure 1A). Here, CASP4 is linked to laryngotracheoesophageal cleft.